Patricia J. Zondervan
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Reply to Jens Borgbjerg, Ole Graumann, and David Breen's's Letter to the Editor re: Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, et al. A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS). Eur Urol Focus. In press. http://dx.doi.org/10.1016/j.euf.2026.06.017.
Journal: European urology focus
Published: August 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].
Journal: European urology open science
Published: June 17, 2026
Think Twice Before You Continue Long-term FU in Localised nccRCC after Surgery.
Journal: European urology oncology
Published: April 22, 2026
Clinical characteristics and follow-up of 77 patients with pathogenic fumarate hydratase variants.
Journal: BJU international
Published: March 19, 2026
Consensus-informed Development of Scoring Systems for Intermediate Laparoscopic Simulation Modules: An ESU Laparoscopic Workgroup Initiative.
Journal: European urology open science
Published: March 12, 2026
Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
Journal: European urology
Published: February 13, 2026
Trends in treatment and survival of older vs younger patients with renal cancer between 2011 and 2022.
Journal: BJU international
Published: December 23, 2025
Health-related Quality of Life in Localized and Metastatic Renal Cell Carcinoma: Insights from Patient-reported Outcome Measures.
Journal: European urology open science
Published: December 17, 2025
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials.
Journal: European urology open science
Published: December 05, 2025
A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).
Journal: European urology focus
Published: October 31, 2025
Clinical outcomes of stereotactic MRI-guided adaptive radiotherapy for renal tumors in patients with a solitary kidney.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 13, 2025
Hospital variation in the treatment of cT1a renal cancer.
Journal: BJUI compass
Published: October 07, 2025
Last Updated: 09/26/2026